Search Results 631-640 of 17587 for Prednisone

  1. Avacopan (oral route) - Side effects & dosage - Mayo Clinic

    Avacopan is used together with steroids to treat severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with ...

  2. Health Topics - Mayo Clinic News Network

    2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to ...

  3. Sirolimus (oral route) - Side effects & dosage - Mayo Clinic

    Sirolimus is used together with other medicines to prevent the body from rejecting a transplanted kidney. It belongs to a group of medicines known as ...

  4. Hyperinflated lungs: What does it mean? - Mayo Clinic

    Chronic obstructive pulmonary disease (COPD) often leads to hyperinflated lungs. COPD is a long-term lung disease that makes it hard for air to flow in and out ...

  5. Update on the management of ANCA-associated vasculitis - Mayo Clinic

    ... prednisone daily. Trial results were published in the New England Journal of Medicine in 2017. For more information. Cartin-Ceba R, et al. Diffuse alveolar ...

  6. Mayo Clinic Neuroimmunology Laboratory Archives

    rapidly reverses with therapy directed at the immune system, such as prednisone, in contrast to infections that need antibiotics and cancer that requires ...

  7. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

    ... prednisone within 30 days before first dose of study treatment on W1D1. Subjects who are currently receiving steroids at a prednisone-equivalent dose of ...

  8. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

    No prior systemic treatment for acute GVHD except for a maximum of 3 days of prednisone (or IV methylprednisolone) ≤2 mg/kg/day. Topical skin steroid ...

  9. A Study to Evaluate Effectiveness of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    Received prednisone doses >15mg/day or changes in immunosuppressive medications < 12 weeks prior to Screening (Visit 1); Recent (within 1 year) history of ...

  10. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

    Phase trial treatment. - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone ...